Keytruda is an immunotherapy drug that is prescribed to cancer patients and is used to treat different types of cancer. It was first approved by the FDA in 2014 for the treatment of advanced or ...

South Korea's Penetrium Bioscience said Wednesday that the company would start a clinical test combining its investigational ...

OptiTROP-Lung05 is the first phase 3 trial of an ADC combined with an immune checkpoint inhibitor to achieve its primary endpoint in first-line NSCLC, Kelun noted. (Kelun-Biotech) With a phase 3 win ...

The Fast Track designation is designed to help promising medicines for serious diseases reach patients faster by allowing more frequent contact with regulators and potentially quicker review.

The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug Summit Therapeutics and Akeso shared more data for their experimental lung-cancer drug ...

A promising new cancer drug helped reduce the risk of death by 34% in patients with the most common form of lung cancer, but investors had a lukewarm response to the data. The highly anticipated ...